CB48121-21A - 0x000000000000747A
Males & Females of Non-Childbearing Potential
Java
* Stipend may pay up to reflected amount.
Start Date:
December 6, 2026 - 8:30am
End Date:
December 19, 2026 - 10:00am
Study Details
Study Number: CB48121
Group Number: 21A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $5,500.00
Study Criteria
Age: 19 - 55
BMI: 18.5 - 30
Weight Restriction: minimum weight 100 lbs
Study Information
Indication: This investigational medication is being developed to treat narcolepsy.
Route of Administration: Oral
Blood Draws: 40
Study Schedule
Schedule Type: Long Term
Study Length: 9 Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Monday | 11/23/2026 |
| Wednesday | 11/25/2026 |
| Monday | 11/30/2026 |
| Tuesday | 12/1/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 12/1/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Sunday | 12/6/2026 8:30:00 AM | Tuesday | 12/15/2026 9:15:00 AM | 1 | Lincoln |
| Return | Saturday | 12/19/2026 7:45:00 AM | Saturday | 12/19/2026 10:00:00 AM | 1 | Lincoln |
